Elisabeth Brinkmann

590 total citations
9 papers, 473 citations indexed

About

Elisabeth Brinkmann is a scholar working on Biotechnology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Elisabeth Brinkmann has authored 9 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biotechnology, 3 papers in Molecular Biology and 3 papers in Clinical Biochemistry. Recurrent topics in Elisabeth Brinkmann's work include Transgenic Plants and Applications (3 papers), Advanced Glycation End Products research (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Elisabeth Brinkmann is often cited by papers focused on Transgenic Plants and Applications (3 papers), Advanced Glycation End Products research (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Elisabeth Brinkmann collaborates with scholars based in United States, Hungary and Pakistan. Elisabeth Brinkmann's co-authors include Kevin J. Wells‐Knecht, John Baynes, Ulrich Brinkmann, Suzanne R. Thorpe, Ira Pastan, Ira Pastan, J. W. Baynes, Mushtaq Ahmed, Mary C. Wells-Knecht and David V. Zyzak and has published in prestigious journals such as Biochemistry, The Journal of Organic Chemistry and Genomics.

In The Last Decade

Elisabeth Brinkmann

9 papers receiving 458 citations

Peers

Elisabeth Brinkmann

CB

MB

EDM

PHYSI

IMMUN

Betty Chan United States

B Lederer Belgium

Motoki Nakao Japan

Jary S. Mayes United States

G. Pons Spain

Olga Coll Spain

Ayenachew Bezawork‐Geleta Australia

Kayoko Yamashita Japan

J A Higgins United Kingdom

Elena Farmaki United States

Betty Chan United States

Elisabeth Brinkmann

54 ×0.3

CB

297 ×1.4

MB

80 ×0.8

EDM

93 ×1.1

PHYSI

208 ×2.7

IMMUN

Citations per year, relative to Elisabeth Brinkmann Elisabeth Brinkmann (= 1×) peers Betty Chan

Countries citing papers authored by Elisabeth Brinkmann

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Brinkmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Brinkmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Brinkmann more than expected).

Fields of papers citing papers by Elisabeth Brinkmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Brinkmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Brinkmann. The network helps show where Elisabeth Brinkmann may publish in the future.

Co-authorship network of co-authors of Elisabeth Brinkmann

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Brinkmann. A scholar is included among the top collaborators of Elisabeth Brinkmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Brinkmann. Elisabeth Brinkmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Yerushalmi, Noga, Ulrich Brinkmann, Elisabeth Brinkmann, Lee H. Pai, & Ira Pastan. (2000). Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes. Cancer Gene Therapy. 7(1). 91–96. 18 indexed citations

2.

Viner, Jaye L., et al.. (1999). Pharmacokinetics and antitumor activity of a bivalent disulfide-stabilized Fv immunotoxin with improved antigen binding to erbB2.. PubMed. 59(16). 4018–22. 33 indexed citations

3.

Brinkmann, Ulrich, Elisabeth Brinkmann, Tapan K. Bera, Axel Wellmann, & Ira Pastan. (1999). Tissue-Specific Alternative Splicing of the CSE1L/CAS (Cellular Apoptosis Susceptibility) Gene. Genomics. 58(1). 41–49. 20 indexed citations

4.

Ogryzko, Vasily, Elisabeth Brinkmann, Bruce H. Howard, Ira Pastan, & Ulrich Brinkmann. (1997). Antisense Inhibition of CAS, the Human Homologue of the Yeast Chromosome Segregation Gene CSE1, Interferes with Mitosis in HeLa Cells. Biochemistry. 36(31). 9493–9500. 25 indexed citations

5.

Wells‐Knecht, Kevin J., Elisabeth Brinkmann, Mary C. Wells-Knecht, et al.. (1996). New biomarkers of Maillard reaction damage to proteins. Nephrology Dialysis Transplantation. 11(supp5). 41–47. 142 indexed citations

6.

Brinkmann, Ulrich, Elisabeth Brinkmann, Maria Gallo, Uwe Scherf, & Ira Pastan. (1996). Role ofCAS, a Human Homologue to the Yeast Chromosome Segregation GeneCSE1, in Toxin and Tumor Necrosis Factor Mediated Apoptosis. Biochemistry. 35(21). 6891–6899. 71 indexed citations

7.

Wells‐Knecht, Kevin J., Elisabeth Brinkmann, & John Baynes. (1995). Characterization of an Imidazolium Salt Formed from Glyoxal and N.alpha.-Hippuryllysine: A Model for Maillard Reaction Crosslinks in Proteins. The Journal of Organic Chemistry. 60(20). 6246–6247. 76 indexed citations

8.

Brinkmann, Ulrich, Elisabeth Brinkmann, & Ira Pastan. (1995). Expression Cloning of cDNAs That Render Cancer Cells Resistant to Pseudomonas and Diphtheria Toxin and Immunotoxins. Molecular Medicine. 1(2). 206–216. 35 indexed citations

9.

Brinkmann, Elisabeth, Kevin J. Wells‐Knecht, Suzanne R. Thorpe, & John Baynes. (1995). Characterization of an imidazolium compound formed by reaction of methylglyoxal and N^α-hippuryllysine. Journal of the Chemical Society Perkin Transactions 1. 2817–2818. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact